Home » Newsletters » BioWorld Asia

BioWorld Asia

May 24, 2000

View Archived Issues

CeNeS Buying Cambridge Neuro In All-Stock Deal Valued At $44M

Antisoma Stock Takes Hit Following Independent Study

Study Of Rare Disorder Provides Clues For New Cancer Therapies

French Researchers Say There Are Only About 30,000 Genes

Oxford GlycoSciences Issued Broad Patent On Proteomics

NicOx Reports Early Phase II Results, Starts Phase I Study

Watson, Arntzen Among Those Adding Input To Israeli Biotech

SkyePharma Changes Strategy, Plans More Development Work

ExonHit, Collaborators Identify Markers Linked To Hypoxia

Queensland Group Develops Genetic Test For Skin Cancer

United Nations Takes Step Toward Labeling GM Food

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...